Read More Analyst Ratings News Price Target Canaccord Genuity Maintains Buy on Wolfspeed, Lowers Price Target to $145 By Benzinga Newsdesk Today, 3:53 AM Canaccord Genuity analyst Jed Dorsheimer maintains Wolfspeed (NYSE:WOLF) with a Buy and lowers the price target from $155 to $145. WOLF
Read More Hot Movers News Rumors Trading Ideas Boeing Shares Move Higher Amid Report Co. Has Told Airlines, Its Suppliers 787 Deliveries Will Resume During H2’22 By Benzinga Newsdesk Today, 3:53 AM -Reuters BA
Read More Cryptocurrency Markets News Top 10 NFTs By Weekly Sales Volume: Bored Apes Hit 100 ETH As Bieber Joins Club, Killer GF, Asuna, Creepz Join Leaderboard By Chris Katje Today, 3:53 AM The non-fungible token market continues to heat up with strong sales volume on OpenSea, an NFT marketplace for buying and selling items. COIN
Read More Biotech General Health Care Large Cap News After Surprise Overall Survival Data In Metastatic Breast Cancer, Gilead Takes Complete Rights To Trodelvy By Vandana Singh Today, 3:53 AM Everest Medicines will transfer all development and commercialization rights of Trodelvy (sacituzumab govitecan) to Gilead Sciences Inc (NASDAQ:GILD) in Greater China, South… GILD